Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Mar 13, 2020 · 10-K · 73 days after period end · 0001564590-20-010642
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Net Income | -$3.19M | -$3.64M | -$3.74M | -$486.00K |
| EPS Diluted | -$5.91 | -$0.55 | -$3.17 | -$22.89 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 13, 2020 · 73 d after period end
